Rom***PhD

Director of Business Development

Bildung

University of Bern

University of Bern (2013 - 2016)

  • Degree: PhD in Immunology
  • Field of Study: Microbiology and Immunology
  • Description: Thesis title: "Application of systems vaccinology to the veterinary field using a Toll-like receptor ligand adjuvanted liposomal vaccine targeting antigen presenting cells"

Universität Bern (2012 - 2013)

  • Degree: Master of Science (M.Sc.)
  • Field of Study: Molecular Life Science
  • Description: Special qualification in Microbiology/Immunology Master thesis at Laboratory Spiez, Spiez, Switzerland: “Evaluation of Liposomal formulations for the delivery of siRNA in a Langat Virus in vitro model”

Universität Konstanz / University of Konstanz (2008 - 2011)

  • Degree: Bachelor of Science (B.Sc.)
  • Field of Study: Biological Sciences
  • Description: Thesis: Chair of Biochemical Pharmacology: “Interactions between LRH-1 and the Glucocorticoid Receptor”

Fähigkeiten:

Immunology, Data Analysis, Project Management, Microbiology

Berufserfahrung:

Director of Business Development at Envisagenics

  • Location:
  • Duration: 2023-06 to Present
  • Description: Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Our breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Our in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.

Business Development Director at Champions Oncology, Inc.

  • Location: Greater Boston
  • Duration: 2022-04 to 2023-05
  • Description:

Sr. Manager, Key Accounts at SIRION BIOTECH GmbH

  • Location: Boston, Massachusetts, United States
  • Duration: 2021-03 to 2022-04
  • Description: • Consulting on custom viral vector manufacturing and engineering for projects across therapeutic areas (gene therapy, cell therapy, oncology, vaccines): AAVs, Adenoviruses, Lentiviruses • Establishing and managing business development activities to build long-term scientific collaborations as well as driving licensing of existing intellectual property. • Identification of prospective clients and advancing them to key accounts through successful project management.

Key Account Manager at SIRION BIOTECH GmbH

  • Location: Boston, Massachusetts, United States
  • Duration: 2019-10 to 2021-02
  • Description:

Postdoctoral Research Fellow in Hematology/Oncology at Boston Children's Hospital at Harvard Medical School

  • Location: Großraum Boston und Umgebung
  • Duration: 2017-06 to 2019-09
  • Description: • Directed laboratory projects to analyze cell death in cancer and viral infection models including MCMV, Zika virus, myeloid leukemia, and hematopoiesis (T cell development). • Developed Flow-FISH pipeline to analyze telomere length from in vivo and ex vivo studies published in Cell Stem Cell. • Managed lab activities as interim lab manager and trained peers, junior staff and students on crucial laboratory techniques (e.g. cell culture, PBMC isolation, multicolor flow cytometry) and handling of rodents. • Coursework: Scientists Teaching Science Course – A Nine-week Pedagogy Course for Postdocs, Introduction into Network Medicine, Python for Life Scientists, Life Science Industries and Non-Academic Careers for PhDs.
KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapLow

No detectable employment gaps; career history shows continuous progression since 2017.

Industry ConsistencyLow

Career blends academic training with increasing industry BD roles; transition from postdoc to biotech partnerships is common and aligns with current path.

Tenure StabilityMedium

Most roles are 1-2 years; while not uncommon in biotech BD, it suggests moderate turnover that could raise questions for longer-term commitments.

Education-Career MatchLow

PhD in immunology from University of Bern aligns with role focus in immunology, virology, and biotech partnerships; strong fit for the US biotech market.

Karrierewachstumskurve

Postdoctoral Research Fellow in Hematology/Oncology Entry
Boston Children's Hospital / Harvard Medical School
2017-06 to 2019-09
Key Account Manager Lateral
SIRION BIOTECH GmbH
2019-10 to 2021-02
Sr. Manager, Key Accounts ↑ Befördert
SIRION BIOTECH GmbH
2021-03 to 2022-04
Business Development Director ↑ Befördert
Champions Oncology, Inc.
2022-04 to 2023-05
Director of Business Development Lateral
Envisagenics
2023-06 to Present
Bewertung:Roman's career shows a clear, upward trajectory within biotech business development, expanding from research-to-BD foundations to executive-level leadership in partnering, licensing, and strategy. He appears ready for senior director-level roles or VP BD responsibilities in biotech/pharma, particularly with gene therapy, RNA therapeutics, or AI-enabled drug discovery platforms.

Bestpassende Rollen (Top 5)

1

Vice President, Business Development – Biotech/Pharma96% Passung

Progressive BD leadership across multiple biotech companies, strong technical background in immunology/virology, and a global network; proven ability to drive partnership conversations and strategic deals.

2

Senior Director/Head of Strategic Partnerships – Immunology/Cancer Therapies93% Passung

Extensive BD experience with key accounts and licensing, plus domain depth in immunology and cell/gene therapy; aligns with large-scale partnership programs and cross-functional leadership.

3

Director/Head of Corporate Development – RNA Therapeutics / Gene Therapy89% Passung

Strong fit for in-licensing, M&A/disposition, and strategic alliances in RNA therapeutics and gene therapy; PhD-based scientific credibility complements BD leadership.

4

Global Partnerships Lead – Immunology/Oncology85% Passung

Global network and experience with cross-regional teams; capable of expanding international collaborations and co-development programs.

5

Director of Strategic Alliances – RNA Therapeutics / AI-Driven Drug Discovery82% Passung

Combination of BD execution and AI-enabled discovery platforms (like Envisagenics) makes him suitable for alliances and licensing in AI-driven therapeutics.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit